title: Current vaccine adjuvants: an overview of a diverse class.
abstract: Numerous compounds are under evaluation as immunological adjuvants for improvement of vaccine performance. This review will briefly summarize some of the many diverse substances that are currently being utilized as vaccine adjuvants in preclinical and clinical studies.
authors.affiliation: Antigenics, Inc., 3 Forbes Road, Lexington, MA 02421, USA.
authors.forename: Charlotte Read
authors.initials: CR
authors.lastname: Kensil
authors.forename: Annie Xiaoyan
authors.initials: AX
authors.lastname: Mo
authors.forename: Alemseged
authors.initials: A
authors.lastname: Truneh
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D018899:CpG Islands; D016207:Cytokines / Q000378:metabolism; D006133:Growth Substances / Q000378:metabolism; D006360:Heat-Shock Proteins / Q000378:metabolism; D006801:Humans; D007107:Immune System; D007111:Immunity, Cellular; D018928:Immunity, Mucosal; D007155:Immunologic Factors / Q000737:chemistry; D008070:Lipopolysaccharides / Q000737:chemistry; D008074:Lipoproteins / Q000737:chemistry; D010457:Peptidoglycan / Q000737:chemistry; D011994:Recombinant Proteins / Q000737:chemistry; D012503:Saponins / Q000737:chemistry; D014612:Vaccines / Q000627:therapeutic use*; D019444:Vaccines, DNA
chemical_list: D000276:Adjuvants, Immunologic; D016207:Cytokines; D006133:Growth Substances; D006360:Heat-Shock Proteins; D007155:Immunologic Factors; D008070:Lipopolysaccharides; D008074:Lipoproteins; D010457:Peptidoglycan; D011994:Recombinant Proteins; D012503:Saponins; D014612:Vaccines; D019444:Vaccines, DNA